These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 27037091)
1. Relationship between pain relief, reduction in pain-associated sleep interference, and overall impression of improvement in patients with postherpetic neuralgia treated with extended-release gabapentin. Mehta N; Bucior I; Bujanover S; Shah R; Gulati A Health Qual Life Outcomes; 2016 Apr; 14():54. PubMed ID: 27037091 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Postherpetic Neuralgia With Gastroretentive Gabapentin: Interaction of Patient Demographics, Disease Characteristics, and Efficacy Outcomes. Kantor D; Panchal S; Patel V; Bucior I; Rauck R J Pain; 2015 Dec; 16(12):1300-1311. PubMed ID: 26409117 [TBL] [Abstract][Full Text] [Related]
3. Relationships Among Pain Quality, Pain Impact, and Overall Improvement in Patients with Postherpetic Neuralgia Treated with Gastroretentive Gabapentin. Freeman R; Wallace MS; Sweeney M; Backonja MM Pain Med; 2015 Oct; 16(10):2000-11. PubMed ID: 26115203 [TBL] [Abstract][Full Text] [Related]
4. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN). Sang CN; Sathyanarayana R; Sweeney M; Clin J Pain; 2013 Apr; 29(4):281-8. PubMed ID: 22801243 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over. Gupta A; Li S Drugs Aging; 2013 Dec; 30(12):999-1008. PubMed ID: 24163280 [TBL] [Abstract][Full Text] [Related]
6. Real-world experience with once-daily gabapentin for the treatment of postherpetic neuralgia (PHN). Markley HG; Dunteman ED; Kareht S; Sweeney M Clin J Pain; 2015 Jan; 31(1):58-65. PubMed ID: 25076463 [TBL] [Abstract][Full Text] [Related]
7. Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies. Rauck RL; Irving GA; Wallace MS; Vanhove GF; Sweeney M J Pain Symptom Manage; 2013 Aug; 46(2):219-28. PubMed ID: 23149085 [TBL] [Abstract][Full Text] [Related]
8. The Effect of a Novel form of Extended-Release Gabapentin on Pain and Sleep in Fibromyalgia Subjects: An Open-Label Pilot Study. North JM; Hong KS; Rauck RL Pain Pract; 2016 Jul; 16(6):720-9. PubMed ID: 26059271 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of gabapentin 1800 mg treatment for post-herpetic neuralgia: a meta-analysis of randomized controlled trials. Fan H; Yu W; Zhang Q; Cao H; Li J; Wang J; Shao Y; Hu X J Clin Pharm Ther; 2014 Aug; 39(4):334-42. PubMed ID: 24806220 [TBL] [Abstract][Full Text] [Related]
10. Different doses of gabapentin formulations for postherpetic neuralgia: A systematical review and meta-analysis of randomized controlled trials. Wang J; Zhu Y J Dermatolog Treat; 2017 Feb; 28(1):65-77. PubMed ID: 27798973 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial. Irving G; Jensen M; Cramer M; Wu J; Chiang YK; Tark M; Wallace M Clin J Pain; 2009; 25(3):185-92. PubMed ID: 19333167 [TBL] [Abstract][Full Text] [Related]
12. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy. Ifuku M; Iseki M; Hidaka I; Morita Y; Komatus S; Inada E Pain Med; 2011 Jul; 12(7):1112-6. PubMed ID: 21692969 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin. Backonja MM; Canafax DM; Cundy KC Pain Med; 2011 Jul; 12(7):1098-108. PubMed ID: 21627766 [TBL] [Abstract][Full Text] [Related]
14. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study. Wallace MS; Irving G; Cowles VE Clin Drug Investig; 2010; 30(11):765-76. PubMed ID: 20818838 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of gabapentin for prevention of postherpetic neuralgia: study protocol for a randomized controlled clinical trial. Rullán M; Bulilete O; Leiva A; Soler A; Roca A; González-Bals MJ; Lorente P; Llobera J; Trials; 2017 Jan; 18(1):24. PubMed ID: 28088231 [TBL] [Abstract][Full Text] [Related]
16. Relationships Among Adverse Events, Disease Characteristics, and Demographics in Treatment of Postherpetic Neuralgia With Gastroretentive Gabapentin. Shaparin N; Slattum PW; Bucior I; Nalamachu S Clin J Pain; 2015 Nov; 31(11):983-91. PubMed ID: 25811794 [TBL] [Abstract][Full Text] [Related]
17. Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial. Chandra K; Shafiq N; Pandhi P; Gupta S; Malhotra S Int J Clin Pharmacol Ther; 2006 Aug; 44(8):358-63. PubMed ID: 16961166 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China. Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113 [TBL] [Abstract][Full Text] [Related]
19. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. Rowbotham M; Harden N; Stacey B; Bernstein P; Magnus-Miller L JAMA; 1998 Dec; 280(21):1837-42. PubMed ID: 9846778 [TBL] [Abstract][Full Text] [Related]
20. Gabapentin for once-daily treatment of post-herpetic neuralgia: a review. Beal B; Moeller-Bertram T; Schilling JM; Wallace MS Clin Interv Aging; 2012; 7():249-55. PubMed ID: 22866002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]